Chemotherapy of advanced ovarian carcinoma: Initial experience using a platinum‐based combination

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Cancer

• Publication date

  1982-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19820501)49:9<1778::AID-CNCR2820490908>3.0.CO;2-ZPMID 6280845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized trial of Melphalan alone versus combination chemotherapy in advanced ovarian cancer

  1980cited by this paper
• Antiemetics for patients treated with antitumor chemotherapy.

  1980cited by this paper
• Response, 'second look' status and survival in stage III-IV epithelial ovarian cancer treated with cis-dichlorodiammine platinum II (cis-platinum), adriamycin (ADR), and cytoxan (CTX)

  1980cited by this paper
• Malignancies of the Ovary, Uterus and Cervix

  1980cited by this paper
• Indications, advantages, and limits of laparoscopy in ovarian cancer.

  1979cited by this paper
• Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.

  1979cited by this paper
• Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation.

  1979cited by this paper
• Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.

  1979cited by this paper
• Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.

  1979cited by this paper
• Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.

  1978cited by this paper
• Treatment of epithelial carcinoma of the ovary: operation, irradiation, and chemotherapy.

  1977cited by this paper
• Second‐look operation in ovarian carcinoma. Postchemotherapy

  1976cited by this paper
• Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.

  1976cited by this paper
• Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.

  1976cited by this paper
• [Carcinoma of the ovary].

  1960cited by this paper

• Comparative study of combination chemotherapy of ovarian cancer: cyclophosphamide, adriamycin and cisplatin versus 5-fluorouracil, cyclophosphamide and mitomycin C.

  2010cites this paper
• [Cisplatin in ovarian cancer: how much and how long?].

  2008cites this paper
• A relevant historical perspective on the current toxicity of IP chemotherapy: implications for the future.

  2007cites this paper
• Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer

  2004cites this paper
• Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.

  1997cites this paper
• Meta-analysis comparing cisplatin total dose intensity and survival.

  1995cites this paper
• Importance of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis.

  1993cites this paper
• Clinical remission criteria for epithelial carcinoma of the ovary.

  1993cites this paper
• Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up

  1992cites this paper
• Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?

  1992cites this paper
• A randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancer.

  1991cites this paper
• Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.

  1991cites this paper
• A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.

  1990cites this paper
• Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.

  1990cites this paper
• A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group Trial II.

  1990cites this paper
• Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients.

  1990cites this paper
• Long-term survival after chemotherapy with cisplatinum, adriamycin and cyclophosphamide for carcinoma of the ovary.

  1990cites this paper
• A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives.

  1989cites this paper
• Complications of Tenckhoff catheter implantation in patients with multiple previous intraabdominal procedures for ovarian carcinoma.

  1988cites this paper
• Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy.

  1988cites this paper
• Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.

  1988cites this paper
• Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer.

  1988cites this paper
• Intraperitoneal chemotherapy for ovarian carcinoma.

  1988cites this paper
• Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.

  1987cites this paper
• Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.

  1987cites this paper
• Cancer Chemotherapy by Infusion

  1987cites this paper
• Intraperitoneal “Belly Bath” Chemotherapy

  1987cites this paper
• Chemotherapy and Surgery in the Treatment of Ovarian Cancer Bulky Disease

  1986cites this paper
• A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.

  1986cites this paper
• [Therapeutic effectiveness of various combination chemotherapy protocols in advanced epithelial ovarian cancer].

  1986cites this paper
• A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.

  1986cites this paper
• Renal damage in mice after treatment with cisplatinum alone or in combination with X-irradiation.

  1986cites this paper
• Combination Chemotherapy in Advanced Ovarian Carcinoma

  1986cites this paper
• Biological Activities of cis-Dichlorodiamineplatinum II and Its Derivatives

  1985cites this paper
• Treatment selection for cancer patients: application of statistical decision theory to the treatment of advanced ovarian cancer.

  1985cites this paper
• Intracavitary chemotherapy.

  1985cites this paper
• Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

  1985cites this paper
• Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.

  1985cites this paper
• Adriamycin and cis-platinum in advanced ovarian cancer.

  1985cites this paper
• Microscopic disease at second‐look laparotomy in advanced ovarian cancer

  1985cites this paper
• Ototoxicity of cis-diamminedichloroplatinum.

  1985cites this paper
• Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study.

  1985cites this paper
• Medical progress: common epithelial cancer of the ovary (second of two parts)

  1985cites this paper
• Common epithelial cancer of the ovary (2).

  1985cites this paper
• The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.

  1985cites this paper
• Cis-platinum and distal renal tubule toxicity.

  1985cites this paper
• Multiagent chemotherapy in advanced ovarian carcinoma

  1985cites this paper
• Chemotherapy followed by whole-abdominal radiation therapy for ovarian cancer

  1985cites this paper
• The Usefulness of the Human Tumour Stem Cell Assay

  1985cites this paper
• Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.

  1984cites this paper
• Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.

  1984cites this paper
• Combination Cisplatin-Based Intracavitary Chemotherapy

  1984cites this paper
• Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5.

  1984cites this paper
• [Chemotherapy of advanced epithelial ovarian carcinoma].

  1984cites this paper
• Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatin

  1984cites this paper
• Second look laparotomy in the management of epithelial cell carcinoma of the ovary.

  1984cites this paper
• A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation.

  1984cites this paper
• [Treatment of advanced ovarian cancer].

  1984cites this paper
• Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancer.

  1983cites this paper